Patent foramen ovale and stroke: What we do and don't know

Reviews in Neurological Diseases

Volumn 2, Issue 1, 2005, Pages 1-7

  Kim, Doojin ^a   Saver, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atrial septal aneurysm; Paradoxical embolus; Patent foramen ovale (PFO); Stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DOPPLER ECHOGRAPHY; ENDOVASCULAR SURGERY; HEART ANEURYSM; HEART ATRIUM SEPTUM DEFECT; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; PARADOXICAL EMBOLISM; REVIEW; RISK FACTOR; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VENOUS THROMBOEMBOLISM;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HEART SEPTAL DEFECTS, ATRIAL; HUMANS;

EID: 16344378236     PISSN: 15452913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Saver JL. Emerging risk factors for stroke: patent foramen ovale, proximal aortic atherosclerosis, antiphospholipid antibodies, and activated protein C resistance. J Stroke Cerebrovasc Dis. 1997;6:167-172.
2. Meister SG, Giossman W, Dexter L, Dalen JE. Paradoxical embolism: diagnosis during life. Am J Med. 1972;53:292-298.
3. Schneider B, Zienkiewicz T, Jansen V, et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol. 1996; 77:1202-1209.
4. Jauss M, Kaps M, Keberle M, et al. A comparison of transesophageal echocardiography and transcranial Doppler sonography with contrast medium for detection of patent foramen ovale. Stroke. 1994;25:1265-1267.
5. Blersch WK, Draganski BM, Holmer SR, et al. Transcranial duplex sonography in the detection of patent foramen ovale. Radiology, 2002; 225:693-699.
6. Stollberger C, Slany J, Schuster I, et al. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med. 1993;119:461-465
7. Modan B, Sharon E, Jelin N. Factors contributing to the incorrect diagnosis of pulmonary embolic disease. Chest. 1972;62:388-393.
8. Corrin B. Paradoxical embolism. Br Heart J. 1964;26:549-553.
9. Johnson BI. Paradoxical embolism. J Clin Pathol. 1951;4:316-332.
10. Cramer SC, Rordorf G, Maki JH, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the paradoxical emboli from large veins in ischemic stroke (PELVIS) study. Stroke. 2004;35:46-50.
11. Overell JR, Bone I, Lees, KR. Interatrial septal abnormalities and stroke: a meta-analysis of case control studies. Neurology. 2000;55:1172-1179.
12. DiTullio MR, Sacco RL, Sciacca RR, et al. Patent foramen ovale and risk of ischemic stroke in a community-The Northern Manhattan study. Stroke. 2003;34:1.
13. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age: a study using transesophageal echocardiography. Stroke. 1993;24:1865-1873.
14. De Castro S, Cartoni D, Ciorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31:2407-2413.
15. Becker K, Skalabrin E, Hallam D, Gill E. Ischemic stroke during sexual intercourse: a report of 4 cases in persons with patent foramen ovale. Arch Neurol. 2004;61:1114-1116.
16. Mas J, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740-1746.
17. Homma S, Sacco RL, DiTullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale. Circulation. 2002; 105:2625-2631.
18. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation. 1999;100:II-171-II-175.
19. Devuyst G, Bogousslavsky J, Ruchat P, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology. 1996;47:1162-1166.
20. Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke. 1997;28:2376-2381.
21. Tsilimingas NB, Reiter V, Kodolitsch YV, et al. Surgical revision of an uncommonly dislocated self-expanding Amplatzer septal occluder device. Ann Thorac Surg. 2004;78:686-687.
22. Goldstein JA, Beardslee MA, Xu H, et al. Infective endocarditis resulting from CardioSEAL closure of a patent foramen ovale. Catheter Cardiovasc Interv. 2002;55:217-220.
23. Anzai H, Child J, Natterson B, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol. 2004;93:426-431.
24. Cetta F, Arruda MJ, Graham LC. Large left atrial thrombus formation despite warfarin therapy after device closure of a patent foramen ovale. Catheter Cardiovasc Interv. 2003;59:396-398.
25. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol. 2004;44:750-758.
26. Off-label practices plague circulatory system device randomized trials. Gray Sheet. 2004; 30:18-19.
27. Messe SR, Silverman IE, Kizer JR, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm. Neurology. 2004;62:1042-1050.